Yes, You Can Have Axial Ankylosing Spondylitis with Normal Inflammatory Markers
Axial ankylosing spondylitis (axSpA) absolutely can occur with normal ESR and CRP levels—in fact, approximately 40-50% of patients with active disease have normal inflammatory markers. 1, 2
Why Normal Inflammatory Markers Don't Rule Out Disease
The evidence is unequivocal on this point:
- ESR and CRP have only 50% sensitivity in patients with AS and early AS 1
- This means half of patients with active disease will have normal values
- Guideline explicitly states: "Spondyloarthritis should not be ruled out based only on negative laboratory results from HLA-B27, C-reactive protein measurement, or erythrocyte sedimentation rate testing" 2
The Data Behind This
Multiple studies confirm the poor correlation between inflammatory markers and disease activity:
- In a study of 851 patients with painful axial AS, only 61% had elevated CRP despite all having active disease 3
- Correlation coefficients between ESR/CRP and disease activity measures (BASDAI, patient assessment) range from only 0.06-0.48 4
- Neither ESR nor CRP is superior for assessing disease activity 5, 4
What Actually Matters for Diagnosis
Instead of relying on inflammatory markers, focus on:
Clinical Features (Most Important)
- Inflammatory back pain (sensitivity 75%, specificity 75%) 1
- Morning stiffness >30 minutes
- Pain at night/early morning
- Improvement with exercise
- Onset before age 45
- Duration >3 months
HLA-B27 Testing
- Sensitivity 90%, specificity 90% 1
- Far superior to ESR/CRP for screening
- Should be ordered when clinical suspicion exists, regardless of inflammatory markers
Imaging
- MRI of sacroiliac joints detects inflammation even when X-rays are normal 1, 2
- X-ray sacroiliitis has only 80% sensitivity and specificity 1
Critical Clinical Pitfall
The most dangerous mistake is excluding axSpA based on normal ESR/CRP alone. This leads to:
- Diagnostic delays averaging 7-10 years
- Progression to irreversible structural damage
- Preventable disability
Research shows that 39-61% of patients with confirmed active axSpA have normal CRP levels 6, 3. The 2017 NICE guidelines explicitly warn against this error 2.
When to Refer to Rheumatology
Refer patients with chronic back pain (>3 months, onset <45 years) if they have:
Either:
- Inflammatory back pain pattern, OR
- HLA-B27 positivity, OR
- Evidence of sacroiliitis on imaging
Do NOT wait for elevated inflammatory markers before referring 2
The Bottom Line on Inflammatory Markers
While elevated ESR/CRP increases post-test probability to only 12% 1, normal values mean nothing—they cannot exclude disease. ESR and CRP are "not suitable parameters for screening" 1 and have been definitively shown to miss half of all cases.
In patients with clinical features suggestive of axSpA, proceed with HLA-B27 testing and consider rheumatology referral regardless of inflammatory marker results.